Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesStabilizing effect of exenatide in a patient with C-peptide-negative diabetes mellitus
Diabetic Medicine, 09/04/09
Paisley AN et al. – This patient with features of both Type 1 and Type 2 diabetes benefited greatly from exenatide with insulin therapy. The improvement seen in glycaemic control could not be attributable to enhanced insulin secretion but could be as a result of a combination of the other incretin effects (postprandial glucagon suppression, delayed gastric emptying and weight loss secondary to increased satiety) all improving insulin sensitivity, reducing insulin dose and smoothing control.
Related Articles
Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 88%
The European Exenatide study of long-term exenatide vs. glimepiride for type 2 diabetes: rationale and patient characteristics
Diabetes, Obesity and Metabolism, 11/12/09
Relevance Score: 88%
Effects of exenatide on circulating glucose, insulin, glucagon, cortisol and catecholamines in healthy volunteers during exercise
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 11/20/09
Relevance Score: 87%
FDA Approves Revisions to Prescribing Information for Diabetes Medications
American Family Physician, 11/06/09
Relevance Score: 87%
Evaluation of exenatide vs. insulin glargine in type 2 diabetes: cost-effectiveness analysis in the German setting
Diabetes, Obesity and Metabolism, 10/06/09
Relevance Score: 87%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Journal of the National Cancer Institute, 12/09/09
Impaired fasting glucose as a treatment target in diabetes management
Current Cardiology Reports, 12/09/09
Nocturnal intermittent hypoxia and the development of type 2 diabetes: the Circulatory Risk in Communities Study (CIRCS)
Diabetologia - Clinical and Experimental Diabetes and Metabolism, 12/09/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: FNCLCC–FFCD 9710
Endocrine-Related Cancer, 12/09/09
A Randomized Controlled Trial of Oxycodone vs Placebo in Patients With PostHerpetic Neuralgia and Painful Diabetic Neuropathy Treated With Pregabalin
The Journal of Pain, 12/09/09
Effectiveness of cabergoline in monotherapy and combined with ketoconazole in the management of Cushing's disease
Pituitary, 12/08/09
Sponsor
Article Search
Sponsor